- List
- By Topic
- On Map
- Search Details
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
x
1 | NCT00688701 | Completed Has Results |
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
361 | All | 18 Years and older (Adult, Senior) | NCT00688701 | EFC6018 EudraCT 2007-005887-29 |
GETGOAL-MONO | May 2008 | December 2009 | December 2009 | June 3, 2008 | December 12, 2016 | December 12, 2016 |
|
2 | NCT02308254 | Unknown † | Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People |
|
|
Interventional | Phase 1 Phase 2 |
|
Other / Industry |
|
|
30 | All | 40 Years to 80 Years (Adult, Senior) | NCT02308254 | 130419 | Lixi | November 2013 | April 2016 | April 2016 | December 4, 2014 | October 29, 2015 |
|